Patents by Inventor Abbas Abdallah

Abbas Abdallah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating amyotrophic lateral sclerosis (ALS)
    Patent number: 12529051
    Abstract: Aspects of the disclosure relate to recombinant gene editing complexes comprising a recombinant gene editing protein and guide RNA (gRNA) that specifically hybridizes to a region of a C90RF72 gene (e.g., a region flanking a G4C2 repeat or within a exonic region of the gene).
    Type: Grant
    Filed: November 9, 2023
    Date of Patent: January 20, 2026
    Assignee: University of Massachusetts
    Inventors: Christian Mueller, Abbas Abdallah
  • METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    Publication number: 20240167025
    Abstract: Aspects of the disclosure relate to recombinant gene editing complexes comprising a recombinant gene editing protein and guide RNA (gRNA) that specifically hybridizes to a region of a C90RF72 gene (e.g., a region flanking a G4C2 repeat or within a exonic region of the gene).
    Type: Application
    Filed: November 9, 2023
    Publication date: May 23, 2024
    Applicant: University of Massachusetts
    Inventors: Christian Mueller, Abbas Abdallah
  • Methods of treating amyotrophic lateral sclerosis (ALS)
    Patent number: 11859179
    Abstract: Aspects of the disclosure relate to recombinant gene editing complexes comprising a recombinant gene editing protein and guide RNA (gRNA) that specifically hybridizes to a region of a C90RF72 gene (e.g., a region flanking a G4C2 repeat or within a exonic region of the gene).
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: January 2, 2024
    Assignee: University of Massachusetts
    Inventors: Christian Mueller, Abbas Abdallah
  • METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    Publication number: 20200354716
    Abstract: Aspects of the disclosure relate to recombinant gene editing complexes comprising a recombinant gene editing protein and guide RNA (gRNA) that specifically hybridizes to a region of a C90RF72 gene (e.g., a region flanking a G4C2 repeat or within a exonic region of the gene).
    Type: Application
    Filed: May 9, 2018
    Publication date: November 12, 2020
    Applicant: University of Massachusetts
    Inventors: Christian Mueller, Abbas Abdallah